Answers are grounded in this paper and cite their sources.
Diabetes is strongly associated with erectile dysfunction, which is itself a risk factor for cardiovascular events and mortality. Evidence shows that phosphodiesterase type 5 inhibitor (PDE5I) use in men with type 2 diabetes mellitus is associated with a significant reduction in all‐cause mortality and morbidity. Despite the evidence, PDE5Is appear to be underused in this male cohort.
No takes yet. Share an insight, caveat, or question.
Hackett et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: